Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02838017 · ClinicalTrials.gov registry record · NA

Tissue Adhesive vs. Sterile Strips After Cesarean Delivery

A NA study, sponsored by Endeavor Health.

Terminated
Registry status
NA
Development phase
504
Enrollment target

NCT02838017: Clinical Trial NA study, sponsored by Endeavor Health.

NCT02838017 is a NA study that was terminated before completion, run by Endeavor Health. The registered enrollment target is 504 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02838017, a NA study, was terminated before completion, sponsored by Endeavor Health.

TERMINATED
Registry status
NA
Development phase
504 participants
Enrollment target

Study Summary

The goal of this project is to identify a strategy to reduce wound complications in women who undergo cesarean delivery by Pfannenstiel skin incision. Currently, many Pfannenstiel skin incisions are closed by subcuticular sutures followed by either placement of sterile strips or tissue A\\adhesive. Either sterile strips or tissue adhesive can be placed over the wound as a covering but it is unclear which may reduce wound complication rates. The hypothesis of this study is that tissue adhesive will result in a reduction in wound complication rates when compared to sterile strips. Previously published studies in non-obstetric populations have identified tissue adhesive as a potential intervention to reduce wound complications. The eligible population for this study will include women at NorthShore University HealthSystem Evanston Hospital and University of Chicago Hospital who will undergo primary or repeat cesarean delivery via Pfannenstiel skin incision. Women in the study will be randomized to receive either sterile strips or tissue adhesive. The primary outcome to be evaluated will be a composite of wound complication which will include drainage, cellulitis, hematoma, seroma and/or wound separation (partial or complete). Secondary endpoints to be investigated include cosmetic outcome, patient satisfaction, cost comparison, and difference in operative times.

Primary Outcome

Wound drainage, Cellulitis, Abscess, Hematoma, Seroma or Separation

Interventions

  • DEVICE Tissue Adhesive
  • DEVICE Sterile strips

Trial Details

FieldValue
Enrollment Target 504 participants
Start Date 2016-11
Est. Completion 2018-06
Phase NA
Endeavor Health

94 total trials

Why NCT02838017 stopped before completion

NCT02838017 is an interventional study that assigns participants to a tested intervention. The registered 504 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).

The record links to 0 conditions, and to 2 interventions - of which Tissue Adhesive is the first listed.

NCT02838017 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02838017 about?

NCT02838017 is a clinical study titled "Tissue Adhesive vs. Sterile Strips After Cesarean Delivery". The goal of this project is to identify a strategy to reduce wound complications in women who undergo cesarean delivery by Pfannenstiel skin incision. Currently, many Pfannenstiel skin incisions are closed by subcuticular sutures followed by either placement of sterile strips or tissue A\\adhesive. ...

What is the current status of trial NCT02838017?

This trial is currently terminated. It is a NA study. The enrollment target is 504 participants. The study started on 2016-11. Estimated completion is 2018-06.

What interventions are being tested in trial NCT02838017?

The interventions under investigation include: Tissue Adhesive (DEVICE), Sterile strips (DEVICE).

Who is sponsoring clinical trial NCT02838017?

This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02838017's enrollment target sits among peer trials

504 193rd of 2000 higher than 1,808 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05846282 · 504 participants · NA

    Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience

  • NCT06072131 · 504 participants · Phase 3

    To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

  • NCT06736522 · 504 participants · NA

    Future Leaders Program: Testing a Youth Leadership, Engagement, and Mindfulness Program

  • NCT06822257 · 504 participants · NA

    Drinking in Young Adult Duos (DYAD) Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02838017, the US trial registry maintained by the National Library of Medicine. NCT02838017 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.